February 23rd, 2023Media Contact:
Elizabeth Mortek
Inprela
Elizabeth@inprela.com
612.677.2025
New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH
Screening with FibroScan® (VCTE™ technology) is recommended for individuals at high risk for NAFLD and NASH
PARIS and Waltham, MA –...